Position in DHR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,763,583
-$392,250 QoQ
Shares Held
40,758
-5.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#529
of 2,098 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Choate Investment Advisors holds $20,090,770 across 7 Diagnostics & Research names. DHR ranks #1 (38.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
This page
|
40,758 | $7,763,583 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
9,506 | $4,765,928 | |
| 3 | ILMN |
Illumina, Inc.
|
19,401 | $3,411,277 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
1,507 | $1,925,207 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,175 | $1,145,007 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
3,745 | $723,608 | |
| 7 | LH |
Labcorp Holdings Inc.
|
1,272 | $356,160 |
All Filings in DHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,763,583 | 40,758 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,155,833 | 43,016 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,751,305 | 42,597 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $8,229,376 | 41,508 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $10,120,566 | 51,233 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,748,560 | 52,432 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,510,325 | 50,143 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $13,110,589 | 47,157 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,217,015 | 44,895 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $10,730,468 | 42,970 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $8,394,865 | 36,288 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,472,093 | 22,056 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $4,464,000 | 18,600 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $4,268,801 | 16,937 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,025,359 | 15,166 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,863,760 | 14,959 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,554,097 | 14,019 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,205,765 | 14,338 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $3,330,238 | 10,122 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,866,606 | 9,416 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,694,602 | 10,041 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $2,031,572 | 9,026 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,987,708 | 8,948 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,956,919 | 9,088 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,622,415 | 9,175 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,269,911 | 9,175 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||